Immuron Ltd ADR (IMRN) Stock Price, Quote & News

Company Profile

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune su...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9824 5254

Fax: 61 3 9822 7735

Website: www.immuron.com.au

Address:

62 Lygon Street, Level 3 Carlton South, Carlton, Australia

topstockalerts May. 29 at 8:01 PM

$IMRN this is moving with a lot more confidence than I expected

1 · Reply

NinoBlackCity May. 29 at 7:50 PM

$IMRN

0 · Reply

KUMO2026 May. 29 at 7:49 PM

$IMRN nice little short off algo 1.55 wash

0 · Reply

Tryitin May. 29 at 7:47 PM

$IMRN Holding up well around 1.43 and this will be a continuation run for next week if we dont see any news today IMO. I was all in early on this and not selling a single share until I see 2.

0 · Reply

KUMO2026 May. 29 at 7:15 PM

$IMRN took a short here

0 · Reply

Tryitin May. 29 at 7:14 PM

$IMRN Looks like AH news might be coming based on price action. HOLD got GOLD!

0 · Reply

whodat2025 May. 29 at 6:58 PM

$IMRN one to watch without a doubt

0 · Reply

NinoBlackCity May. 29 at 6:40 PM

$IMRN Hmmmmmmm. Juicy 🤤

0 · Reply

Tryitin May. 29 at 6:38 PM

$IMRN Rapid raise is beginning soon. BUCKLE UP!

0 · Reply

Vinniesb May. 29 at 6:35 PM

$IMRN Let’s get some news and get the really big move!!

0 · Reply

Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00

Fri, 17 Apr 2026 06:00:00 -0400 - 6 weeks ago

Immuron Double Digit 3Q Sales Growth

Thu, 05 Mar 2026 11:05:00 -0500 - 3 months ago

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target

2026-03-05T11:00:00.000Z - 3 months ago

Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference

Thu, 22 Jan 2026 06:00:00 -0500 - 4 months ago

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target

Mon, 19 Jan 2026 06:00:00 -0500 - 4 months ago

Immuron Reports Continued Sales Growth

2025-12-10T13:49:49.000Z - 6 months ago

Why Is Immuron Stock (IMRN) Down Today?

2025-12-03T11:53:11.000Z - 6 months ago

Immuron (IMRN) Collaborates on Vaccine Research with US Military Institutes

2025-12-03T11:10:43.000Z - 6 months ago

Immuron anounces new DoD award and clinical trial updates

2025-11-05T11:58:49.000Z - 7 months ago

Immuron (IMRN) Secures FDA Approval for Phase 2 Trial of IMM-529

2025-11-05T11:25:57.000Z - 7 months ago

Immuron announces FDA approval of IND for IMM-529

2025-11-05T11:25:02.000Z - 7 months ago

Immuron: FDA Approves IND Application For IMM-529

Wed, 05 Nov 2025 06:00:00 -0500 - 7 months ago

Immuron IMM-529 IND approved by FDA

Fri, 17 Oct 2025 11:07:00 -0400 - 8 months ago

Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target

2025-10-13T12:54:51.000Z - 8 months ago

Immuron Announces Rise In Global Revenue For Q1

Mon, 13 Oct 2025 06:00:00 -0400 - 8 months ago

Immuron Q1 FY26 YoY growth

2025-10-08T11:31:48.000Z - 8 months ago

Immuron (IMRN) Seeks FDA Green Light for Novel C. diff Treatment

2025-10-08T10:16:00.000Z - 8 months ago

Why Immuron Is Rising In Pre-market?

2025-10-08T10:05:07.000Z - 8 months ago

Immuron submitts IND application to FDA for clinical development of IMM-529

Wed, 08 Oct 2025 06:00:00 -0400 - 8 months ago

Immuron Submits IMM-529 IND to FDA

2025-10-02T11:26:44.000Z - 8 months ago

Immuron (IMRN) Updates Shareholders on Key Project Developments

2025-10-02T10:20:08.000Z - 8 months ago

Immuron announces projects update

Thu, 02 Oct 2025 06:00:00 -0400 - 8 months ago

Immuron Letter to Shareholders – Projects Update

2025-08-27T09:20:17.000Z - 9 months ago

Immuron enters partnership with InvestorHub

Tue, 26 Aug 2025 22:29:00 -0400 - 9 months ago

Immuron partners with InvestorHub

2025-07-17T10:05:32.000Z - 11 months ago

Immuron says FY25 global sales exceed projection, up 49% over prior year

Thu, 17 Jul 2025 06:00:00 -0400 - 11 months ago

Immuron - FY25 global sales exceed projection, up 49% on prior year

Fri, 30 May 2025 06:00:00 -0400 - 1 year ago

Immuron Letter to Shareholders: Projects Update

2025-04-11T08:55:40.000Z - 1 year ago

Immuron (IMRN) Achieves Record Sales Milestone

Thu, 10 Apr 2025 18:00:00 -0400 - 1 year ago

Immuron Travelan® highest sales in history

2025-03-05T11:06:32.000Z - 1 year ago

Immuron partners with Calmino to distribute ProIBS in Australia, New Zealand

Wed, 05 Mar 2025 06:00:00 -0500 - 1 year ago

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

2025-01-17T11:10:11.000Z - 1 year ago

Immuron reports strong sales growth of Travelan

Fri, 17 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Travelan® continued strong sales growth

2025-01-15T11:05:46.000Z - 1 year ago

Immuron announces research collaboration agreement with Monash University

Wed, 15 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

2025-01-14T11:10:34.000Z - 1 year ago

Immuron announces Travelan clinical trial update

Tue, 14 Jan 2025 06:00:00 -0500 - 1 year ago

Immuron Announces Travelan® Clinical Trial Update

Mon, 02 Dec 2024 06:00:00 -0500 - 1 year ago

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Thu, 21 Nov 2024 18:33:00 -0500 - 1 year ago

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

Mon, 18 Nov 2024 08:30:00 -0500 - 1 year ago

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

Wed, 16 Oct 2024 06:00:00 -0400 - 1 year ago

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

2024-10-15T10:10:20.000Z - 1 year ago

Immuron reports Q3 sales of Travelan up 13% vs. Q2

Tue, 15 Oct 2024 06:00:00 -0400 - 1 year ago

Immuron Travelan® continued strong sales growth

2024-10-05T09:06:00.000Z - 1 year ago

Immuron says NMRC completes interim analysis for evaluation in Campylobacter

Fri, 04 Oct 2024 06:30:00 -0400 - 1 year ago

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

2024-10-02T23:10:07.000Z - 1 year ago

Immuron trading halted, news pending

2024-09-26T13:25:16.000Z - 1 year ago

Immuron initiated with a Buy at Litchfield Hills

Thu, 19 Sep 2024 09:42:00 -0400 - 1 year ago

Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma

2024-09-14T11:17:07.000Z - 1 year ago

Immuron Ltd Webinar Presentation Transcript

2024-09-05T16:00:45.000Z - 1 year ago

Immuron plans Phase 2 trial for IMM-529 following FDA review

Sep 5, 2024, 11:54 AM EDT - 1 year ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS GOVX

2024-08-16T10:02:59.000Z - 1 year ago

Immuron announces new DoD research award for NMRC

Aug 16, 2024, 6:00 AM EDT - 1 year ago

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

Aug 15, 2024, 6:14 PM EDT - 1 year ago

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Aug 7, 2024, 6:00 AM EDT - 1 year ago

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

2024-07-15T12:10:03.000Z - 2 years ago

Immuron announces record Travelen sales globally

Jul 2, 2024, 6:00 AM EDT - 2 years ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing

May 31, 2024, 6:00 AM EDT - 2 years ago

Immuron Board Changes

May 31, 2024, 6:00 AM EDT - 2 years ago

Immuron CEO Steven Lydeamore to present at Peak Sky High

May 7, 2024, 6:00 AM EDT - 2 years ago

Immuron Limited to Present at the Emerging Growth Conference

May 3, 2024, 6:00 AM EDT - 2 years ago

Immuron Director Resignation

Apr 15, 2024, 6:00 AM EDT - 2 years ago

Immuron to host Live Virtual Event

Apr 10, 2024, 6:00 AM EDT - 2 years ago

Immuron Travelan® sales continued strong growth

Mar 7, 2024, 6:00 AM EST - 2 years ago

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Feb 21, 2024, 6:00 AM EST - 2 years ago

Immuron Presentation Australian Biologics Festival 2024

Feb 13, 2024, 6:00 AM EST - 2 years ago

Immuron achieves record Travelan® sales

Feb 8, 2024, 6:00 AM EST - 2 years ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Jan 16, 2024, 6:00 AM EST - 2 years ago

Immuron achieves record half yearly Travelan® sales

Dec 22, 2023, 6:00 AM EST - 2 years ago

Immuron Clinical Trials Update

Dec 4, 2023, 6:00 AM EST - 2 years ago

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

Nov 13, 2023, 6:00 PM EST - 2 years ago

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Oct 30, 2023, 7:21 AM EDT - 2 years ago

Immuron CEO Steven Lydeamore presented at AusBioInvest

Oct 18, 2023, 6:00 AM EDT - 2 years ago

Immuron Announces Travelan® Clinical Study Cohort 2 commences

Oct 11, 2023, 6:00 AM EDT - 2 years ago

Immuron achieves record quarterly Travelan® sales

Sep 18, 2023, 7:30 AM EDT - 2 years ago

Immuron Limited Announces Participation in the LD Micro Main Event XVI

Sep 13, 2023, 6:00 AM EDT - 2 years ago

Immuron achieves record monthly Travelan® sales

Sep 11, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

topstockalerts May. 29 at 8:01 PM

$IMRN this is moving with a lot more confidence than I expected

1 · Reply

NinoBlackCity May. 29 at 7:50 PM

$IMRN

0 · Reply

KUMO2026 May. 29 at 7:49 PM

$IMRN nice little short off algo 1.55 wash

0 · Reply

Tryitin May. 29 at 7:47 PM

$IMRN Holding up well around 1.43 and this will be a continuation run for next week if we dont see any news today IMO. I was all in early on this and not selling a single share until I see 2.

0 · Reply

KUMO2026 May. 29 at 7:15 PM

$IMRN took a short here

0 · Reply

Tryitin May. 29 at 7:14 PM

$IMRN Looks like AH news might be coming based on price action. HOLD got GOLD!

0 · Reply

whodat2025 May. 29 at 6:58 PM

$IMRN one to watch without a doubt

0 · Reply

NinoBlackCity May. 29 at 6:40 PM

$IMRN Hmmmmmmm. Juicy 🤤

0 · Reply

Tryitin May. 29 at 6:38 PM

$IMRN Rapid raise is beginning soon. BUCKLE UP!

0 · Reply

Vinniesb May. 29 at 6:35 PM

$IMRN Let’s get some news and get the really big move!!

0 · Reply

Tryitin May. 29 at 6:17 PM

$IMRN Will this have a rapid raise AH like how it did earlier this week. Lets see how it plays....Great move today and still looking strong! Keep it going!

0 · Reply

traitor4life May. 29 at 6:16 PM

$IMRN will be ready soon…

0 · Reply

PumpyDumby May. 29 at 6:10 PM

$IMRN only 1137 stocks per person?

0 · Reply

NinoBlackCity May. 29 at 6:09 PM

$IMRN hmmmmmmm

0 · Reply

Tryitin May. 29 at 5:53 PM

$IMRN ITs breaking a major resitance now and it may go faster from here....Cheers to bulls! Lets Go!

0 · Reply

click_420 May. 29 at 5:23 PM

$IMRN I wasn't finish filling my position but looking to add more on any pull back

0 · Reply

Tryitin May. 29 at 5:12 PM

$IMRN Keep it going baby!

0 · Reply

Tryitin May. 29 at 4:46 PM

$IMRN Glad to see this consolidated above 1 as I anticipated and moving up gradually. I think we will see 1.5 thru 1.8 ranges by next week. All the shorts trapped here for the last 3 days have to cover at some point! Keep it going!.

0 · Reply

Zipcash May. 29 at 3:15 PM

$IMRN it will break $2.00’s next week

0 · Reply

ZeebraNotZebra May. 29 at 1:49 PM

$IMRN can it break $1.30 today?

0 · Reply

BigBoyTroy May. 29 at 9:51 AM

$IMRN in my watchlist free discord link in my stoctwits profile/ bio

0 · Reply

RayTex May. 28 at 11:56 PM

$IMRN I’m thinking some positive results will follow in the next few days. Easy hold on this one.

2 · Reply

Market Cap	9.96M
Revenue (ttm)	4.72M
Net Income (ttm)	-3.38M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-71.61%
Debt to Equity Ratio	0.00

Volume	577,100
Avg Vol	266,108
Day's Range	N/A - N/A
Shares Out	8.17M
Stochastic %K	84%
Beta	0.87
Analysts	Strong Buy
Price Target	$5.00